Your browser doesn't support javascript.
loading
Functional abdominal pain disorders and patient- and parent-reported outcomes in children with inflammatory bowel disease in remission.
Tran, Léa Chantal; Bridoux-Henno, Laure; Gastineau, Swellen; Dabadie, Alain; Carré, Emilie; Hugot, Jean-Pierre; Martinez-Vinson, Christine; Mosca, Alexis; Coopman, Stéphanie; Lamireau, Thierry; Enaud, Raphaël; Clouzeau, Haude; Bertrand, Valérie; Pigneur, Bénédicte; Ruemmele, Frank; Degas, Vanessa; Breton, Anne; Mas, Emmanuel; Lacotte, Édouard; Chaillou-Legault, Emilie; Caron, Nicolas; Languepin, Jane; Willot, Stéphanie; Bouazza, Ahlem; Spyckerelle, Claire; Dimitrov, Georges; Thomassin, Nadège; Djeddi, Djamal; Vanrenterghem, Audrey; Grandjean, Camille; Viala, Jérôme; Dupont-Lucas, Claire.
Afiliação
  • Tran LC; Service de Pédiatrie, CHU d'Amiens, Amiens F-80000, France; INFINITE - INSERM U1286, Pôle Recherche 5ème étage Epicenter Est, CHU de Lille, Institute for Translational Research in Inflammation, Université de Lille, 1 Place Verdun, Lille F-59045, France.
  • Bridoux-Henno L; Service de Gastroentérologie Pédiatrique, CHU de Rennes, Rennes F-35033, France.
  • Gastineau S; Service de Gastroentérologie Pédiatrique, CHU de Rennes, Rennes F-35033, France.
  • Dabadie A; Service de Gastroentérologie Pédiatrique, CHU de Rennes, Rennes F-35033, France.
  • Carré E; Service de Gastroentérologie Pédiatrique, CHU de Rennes, Rennes F-35033, France.
  • Hugot JP; Service de Gastroentérologie, Hépatologie et Nutrition Pédiatriques, CHU Robert-Debré, Assistance Publique-Hôpitaux de Paris, Paris F-75019, France; INSERM 1149, Université de Paris, Paris F-75019, France.
  • Martinez-Vinson C; Service de Gastroentérologie, Hépatologie et Nutrition Pédiatriques, CHU Robert-Debré, Assistance Publique-Hôpitaux de Paris, Paris F-75019, France.
  • Mosca A; Service de Gastroentérologie, Hépatologie et Nutrition Pédiatriques, CHU Robert-Debré, Assistance Publique-Hôpitaux de Paris, Paris F-75019, France.
  • Coopman S; Service de Gastroentérologie et Nutrition Pédiatriques, Hôpital Jeanne de Flandre, CHU de Lille, Lille F-59000, France.
  • Lamireau T; Service de Gastroentérologie Pédiatrique, CHU de Bordeaux, Bordeaux F-33000, France.
  • Enaud R; Service de Gastroentérologie Pédiatrique, CHU de Bordeaux, Bordeaux F-33000, France.
  • Clouzeau H; Service de Gastroentérologie Pédiatrique, CHU de Bordeaux, Bordeaux F-33000, France.
  • Bertrand V; Service de Pédiatrie, CH Le Havre, Le Havre F-76083, France.
  • Pigneur B; Service de Gastroentérologie Pédiatrique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris F-75015, France; INSERM UMR S 1139, Faculté de Pharmacie, Université de Paris, France.
  • Ruemmele F; Service de Gastroentérologie Pédiatrique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris F-75015, France; INSERM Imagine UMR 1163, Université de Paris, France.
  • Degas V; Service de Pédiatrie, Center Hospitalier Sud Francilien, Corbeil-Essonnes F-91100, France.
  • Breton A; Unité de Gastroentérologie, Hépatologie, Nutrition, et Maladies Héréditaires du Métabolisme, Hôpital des Enfants, CHU de Toulouse, IRSD Universiy, Toulouse, France.
  • Mas E; Unité de Gastroentérologie, Hépatologie, Nutrition, et Maladies Héréditaires du Métabolisme, Hôpital des Enfants, CHU de Toulouse, IRSD Universiy, Toulouse, France; INSERM, INRAE, ENVT, UPS, F-31300, France.
  • Lacotte É; Unité de Gastroentérologie, Hépatologie, Nutrition, et Maladies Héréditaires du Métabolisme, Hôpital des Enfants, CHU de Toulouse, IRSD Universiy, Toulouse, France; Service de Pédiatrie, Université de Normandie, UNICAEN, CHU de Caen Normandie, Caen F-14000, France.
  • Chaillou-Legault E; Service de Pédiatrie, CHU d'Angers, Angers F-49100, France.
  • Caron N; Service de Pédiatrie, CHU de Clermont-Ferrand, Clermont-Ferrand F-63003, France.
  • Languepin J; Service de Pédiatrie, CHU de Limoges, Limoges F-87000, France.
  • Willot S; Service de Pédiatrie, CHU de Tours, Tours F-37000, France.
  • Bouazza A; Service de Gastroentérologie Pédiatrique, CHU Saint Vincent de Paul, Lille F-59000, France.
  • Spyckerelle C; Service de Gastroentérologie Pédiatrique, CHU Saint Vincent de Paul, Lille F-59000, France.
  • Dimitrov G; Service de Pédiatrie, CH d'Orléans, Orléans F-45100, France.
  • Thomassin N; Service de Pédiatrie, CHU de Grenoble, Grenoble, France.
  • Djeddi D; Service de Pédiatrie, CHU d'Amiens, Amiens F-80000, France.
  • Vanrenterghem A; Service de Pédiatrie, CHU d'Amiens, Amiens F-80000, France.
  • Grandjean C; Service de Pédiatrie, Université de Normandie, UNICAEN, CHU de Caen Normandie, Caen F-14000, France.
  • Viala J; Service de Gastroentérologie, Hépatologie et Nutrition Pédiatriques, CHU Robert-Debré, Assistance Publique-Hôpitaux de Paris, Paris F-75019, France; INSERM 1149, Université de Paris, Paris F-75019, France.
  • Dupont-Lucas C; Service de Pédiatrie, Université de Normandie, UNICAEN, CHU de Caen Normandie, Caen F-14000, France; INSERM UMR 1073, Univ. Rouen, Rouen F-76000, France.
Dig Liver Dis ; 53(10): 1268-1275, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34187767
ABSTRACT

BACKGROUND:

Chronic abdominal pain occurs frequently in pediatric patients with inflammatory bowel disease (IBD) in remission.

AIMS:

To assess the prevalence and factors associated with Functional Abdominal Pain Disorders among IBD children in remission (IBD-FAPD).

METHODS:

Patients with IBD for > 1 year, in clinical remission for ≥ 3 months were recruited from a National IBD network. IBD-FAPDs were assessed using the Rome III questionnaire criteria. Patient- or parent- reported outcomes were assessed.

RESULTS:

Among 102 included patients, 57 (56%) were boys, mean age (DS) was 15.0 (± 2.0) years and 75 (74%) had Crohn's disease. Twenty-two patients (22%) had at least one Functional Gastrointestinal Disorder among which 17 had at least one IBD-FAPD. Past severity of disease or treatments received and level of remission were not significantly associated with IBD-FAPD. Patients with IBD-FAPD reported more fatigue (peds-FACIT-F 35.9 ± 9.8 vs. 43.0 ± 6.9, p = 0.01) and a lower HR-QoL (IMPACT III 76.5 ± 9.6 vs. 81.6 ± 9.2, p = 0.04) than patients without FAPD, and their parents had higher levels of State and Trait anxiety than the other parents.

CONCLUSIONS:

Prevalence of IBD-FAPD was 17%. IBD-FAPD was not associated with past severity of disease, but with fatigue and lower HR-QoL.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doenças Inflamatórias Intestinais / Dor Abdominal Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doenças Inflamatórias Intestinais / Dor Abdominal Idioma: En Ano de publicação: 2021 Tipo de documento: Article